Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Breast 1

Conditions

Lung Neoplasms 3Breast Neoplasms 3Hematopoietic and Lymphatic System Neoplasm 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Neoplastic Syndromes, Hereditary 1Malignant Solid Neoplasm 1Cigarette Smoking-Related Carcinoma 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Health Promotion × Clear all
NCT04783168 2026-04-16

AIRTECH

M.D. Anderson Cancer Center

Phase NA Recruiting
240 enrolled
Thoracic

Lung Neoplasms

NCT05978128 2025-11-10

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Jonsson Comprehensive Cancer Center

Phase NA Recruiting
800 enrolled
BreastThoracic

Breast Neoplasms, Lung Neoplasms

NCT05407168 2025-04-09

iDECIDE

OHSU Knight Cancer Institute

Phase NA Recruiting
300 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡